SK Chemicals denies acquisition of Ildong Pharm

Published: 2007-07-31 07:00:00

Updated: 2007-07-31 07:00:00

"It's not true that our company would take over Ildong Pharm," said SK Chemicals in a regulatory filing on July 27.

Nevertheless, a top executive of SK Chemicals said on July 26 that it is seeking to take over Ildong Pharm with sales volume of 300 billion won.

SK Chemicals CEO and President...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK